R&D | April 14, 2026
Aragen launches ChemiSHE, India’s first women-led chemistry synthesis lab
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
Panacea Biotec receives LoA from CMSS
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
The event also featured discussions on emerging trends in joint replacement surgery
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The nationwide campaign, running from April 9–23 highlights the first 1,000 days, nutrition, responsive caregiving and play-based learning as critical pillars for children
The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies
Subscribe To Our Newsletter & Stay Updated
